# FDA Inspection 1296662 - Infusyn Therapeutics - November 20, 2025

Source: https://www.keypedia.com/records/fda_inspections/infusyn-therapeutics/93c0b0a3-2fc2-4f20-9966-05bb63833ad6
Source feed: FDA_Inspections

> FDA Inspection 1296662 for Infusyn Therapeutics on November 20, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1296662
- Company Name: Infusyn Therapeutics
- Inspection Date: 2025-11-20
- Classification: No Action Indicated (NAI)
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices

## Related Documents

- [FDA Inspection 1296662 - 2025-11-20](https://www.keypedia.com/records/fda_inspections/infusyn-therapeutics/cb250aef-d94d-45dd-8e18-62c7c1cad7d4)
- [FDA Inspection 1296662 - 2025-11-20](https://www.keypedia.com/records/fda_inspections/infusyn-therapeutics/f10bd96c-2525-4dc7-825e-4cb4ca55f5c6)

Company: https://www.keypedia.com/companies/infusyn-therapeutics/7335550c-6ebf-4801-b9bb-29f54f4ec928